Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Hypertension is a condition that develops when your blood pressure is too high. An antihypertensive is a drug used to treat high blood pressure.
The report presented by Global Market Monitor provides a detailed analysis of the various factors driving the growth of the global Antihypertensive Drugs market. This report describes the range of different sectors and applications that could potentially impact the future market and provides a yield analysis of the global Antihypertensive Drugs market over the forecast period. The increasing prevalence of diabetes increases the risk of developing high blood pressure. Therefore, the increase in the number of people with these risk factors is expected to increase the number of people with hypertension. In turn, this is expected to facilitate the use of existing drugs, which will drive growth in the global antihypertensive drug market over the forecast period. Generic drugs, however, contain the same active ingredient in the same amount as the brand name drug. Generic drug development is simple and less time-consuming. This may hinder the growth of Antihypertensive Drugs market. Antihypertensive Drugs Market is projected to grow at a CAGR of 5% from 2020 to 2026.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Antihypertensive Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Antihypertensive Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Antihypertensive Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Ranbaxy Laboratories
Merck
Astra Zeneca
Johnson & Johnson
Pfizer
United Therapeutics
Sanofi
Novartis
Actelion
Lupin
Takeda
Daiichi Sankyo
By Type:
ARB
CCB
Other
By End-User:
Hypertension
PAH
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Antihypertensive Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Antihypertensive Drugs Market Size and Growth Rate of ARB from 2016 to 2027
-
1.3.2 China Antihypertensive Drugs Market Size and Growth Rate of CCB from 2016 to 2027
-
1.3.3 China Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Antihypertensive Drugs Market Size and Growth Rate of Hypertension from 2016 to 2027
-
1.4.2 China Antihypertensive Drugs Market Size and Growth Rate of PAH from 2016 to 2027
-
1.4.3 China Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Antihypertensive Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Antihypertensive Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of ARB
-
3.4.2 Market Size and Growth Rate of CCB
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Antihypertensive Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Antihypertensive Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Antihypertensive Drugs in Hypertension
-
4.4.2 Market Size and Growth Rate of Antihypertensive Drugs in PAH
-
4.4.3 Market Size and Growth Rate of Antihypertensive Drugs in Other
5 Market Analysis by Regions
-
5.1 China Antihypertensive Drugs Production Analysis by Regions
-
5.2 China Antihypertensive Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Antihypertensive Drugs Landscape Analysis
-
6.1 North China Antihypertensive Drugs Landscape Analysis by Major Types
-
6.2 North China Antihypertensive Drugs Landscape Analysis by Major End-Users
7 Central China Antihypertensive Drugs Landscape Analysis
-
7.1 Central China Antihypertensive Drugs Landscape Analysis by Major Types
-
7.2 Central China Antihypertensive Drugs Landscape Analysis by Major End-Users
8 South China Antihypertensive Drugs Landscape Analysis
-
8.1 South China Antihypertensive Drugs Landscape Analysis by Major Types
-
8.2 South China Antihypertensive Drugs Landscape Analysis by Major End-Users
9 East China Antihypertensive Drugs Landscape Analysis
-
9.1 East China Antihypertensive Drugs Landscape Analysis by Major Types
-
9.2 East China Antihypertensive Drugs Landscape Analysis by Major End-Users
10 Northeast China Antihypertensive Drugs Landscape Analysis
-
10.1 Northeast China Antihypertensive Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Antihypertensive Drugs Landscape Analysis by Major End-Users
11 Southwest China Antihypertensive Drugs Landscape Analysis
-
11.1 Southwest China Antihypertensive Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Antihypertensive Drugs Landscape Analysis by Major End-Users
12 Northwest China Antihypertensive Drugs Landscape Analysis
-
12.1 Northwest China Antihypertensive Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Antihypertensive Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Ranbaxy Laboratories
-
13.1.1 Ranbaxy Laboratories Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Merck
-
13.2.1 Merck Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Astra Zeneca
-
13.3.1 Astra Zeneca Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Johnson & Johnson
-
13.4.1 Johnson & Johnson Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Pfizer
-
13.5.1 Pfizer Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 United Therapeutics
-
13.6.1 United Therapeutics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Sanofi
-
13.7.1 Sanofi Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Novartis
-
13.8.1 Novartis Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Actelion
-
13.9.1 Actelion Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Lupin
-
13.10.1 Lupin Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Takeda
-
13.11.1 Takeda Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Daiichi Sankyo
-
13.12.1 Daiichi Sankyo Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of ARB from 2016 to 2027
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of CCB from 2016 to 2027
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of Hypertension from 2016 to 2027
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of PAH from 2016 to 2027
-
Figure China Antihypertensive Drugs Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Antihypertensive Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Antihypertensive Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Antihypertensive Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Antihypertensive Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Antihypertensive Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of ARB
-
Figure Market Size and Growth Rate of CCB
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Antihypertensive Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Antihypertensive Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hypertension
-
Figure Market Size and Growth Rate of PAH
-
Figure Market Size and Growth Rate of Other
-
Table China Antihypertensive Drugs Production by Regions
-
Table China Antihypertensive Drugs Production Share by Regions
-
Figure China Antihypertensive Drugs Production Share by Regions in 2016
-
Figure China Antihypertensive Drugs Production Share by Regions in 2021
-
Figure China Antihypertensive Drugs Production Share by Regions in 2027
-
Table China Antihypertensive Drugs Consumption by Regions
-
Table China Antihypertensive Drugs Consumption Share by Regions
-
Figure China Antihypertensive Drugs Consumption Share by Regions in 2016
-
Figure China Antihypertensive Drugs Consumption Share by Regions in 2021
-
Figure China Antihypertensive Drugs Consumption Share by Regions in 2027
-
Table North China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table North China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure North China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure North China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table North China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure North China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure North China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Central China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Central China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Central China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Central China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Central China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Central China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Central China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table South China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table South China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure South China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure South China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table South China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure South China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure South China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table East China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table East China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure East China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure East China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table East China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure East China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure East China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Northeast China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Northeast China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Northeast China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Southwest China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Southwest China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Southwest China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Antihypertensive Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Antihypertensive Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Antihypertensive Drugs Consumption Share by Types in 2016
-
Figure Northwest China Antihypertensive Drugs Consumption Share by Types in 2021
-
Figure Northwest China Antihypertensive Drugs Consumption Share by Types in 2027
-
Table Northwest China Antihypertensive Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Antihypertensive Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Antihypertensive Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Antihypertensive Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Antihypertensive Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Ranbaxy Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ranbaxy Laboratories
-
Figure Sales and Growth Rate Analysis of Ranbaxy Laboratories
-
Figure Revenue and Market Share Analysis of Ranbaxy Laboratories
-
Table Product and Service Introduction of Ranbaxy Laboratories
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Astra Zeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zeneca
-
Figure Sales and Growth Rate Analysis of Astra Zeneca
-
Figure Revenue and Market Share Analysis of Astra Zeneca
-
Table Product and Service Introduction of Astra Zeneca
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of United Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Therapeutics
-
Figure Sales and Growth Rate Analysis of United Therapeutics
-
Figure Revenue and Market Share Analysis of United Therapeutics
-
Table Product and Service Introduction of United Therapeutics
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Actelion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actelion
-
Figure Sales and Growth Rate Analysis of Actelion
-
Figure Revenue and Market Share Analysis of Actelion
-
Table Product and Service Introduction of Actelion
-
Table Company Profile and Development Status of Lupin
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lupin
-
Figure Sales and Growth Rate Analysis of Lupin
-
Figure Revenue and Market Share Analysis of Lupin
-
Table Product and Service Introduction of Lupin
-
Table Company Profile and Development Status of Takeda
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda
-
Figure Sales and Growth Rate Analysis of Takeda
-
Figure Revenue and Market Share Analysis of Takeda
-
Table Product and Service Introduction of Takeda
-
Table Company Profile and Development Status of Daiichi Sankyo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo
-
Figure Sales and Growth Rate Analysis of Daiichi Sankyo
-
Figure Revenue and Market Share Analysis of Daiichi Sankyo
-
Table Product and Service Introduction of Daiichi Sankyo
-
